SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-003984
Filing Date
2024-01-26
Accepted
2024-01-26 17:15:12
Documents
13
Period of Report
2024-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51624
2 ex99-1.htm EX-99.1 23326
  Complete submission text file 0001493152-24-003984.txt   258251

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE dare-20240123.xsd EX-101.SCH 3033
4 XBRL LABEL FILE dare-20240123_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE dare-20240123_pre.xml EX-101.PRE 22371
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3305
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 24568916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)